ADINA CATALOGUE
Shop the
complete catalogue.
Search by product name or browse by category. Price, availability and the most important distinction stay visible throughout.
Showing 25–48 of 57 results
-
Experimental
HY Hair Skin Nails
£49.99Batch file pendingThis is a named formulation rather than one defined peptide, making verified composition and batch documentation central to…
Available · 10 in stockAdd to basket -
Experimental
IGF-1 DES
£62.001 mgBatch file pendingA short-acting truncated analogue, contrasted with the extended long-exposure design of IGF-1 LR3.
UnavailableAsk about availability -
Experimental
IGF-1 LR3
£47.991 mgBatch file pendingDesigned for longer, less binding-protein-restricted IGF signalling than native IGF-1 or IGF-1 DES.
Available · 10 in stockAdd to basket -
Early human evidence
Ipamorelin
Price range: £34.99 through £54.995 mgBatch file pendingA ghrelin-receptor secretagogue—not a GHRH analogue—and generally discussed as more selective than older GHRPs.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Human clinical research
Kisspeptin-10
£54.00Batch file pendingKisspeptin-10 acts for a shorter time than Kisspeptin-54, making the length of the research signal the clearest difference.
Available · 10 in stockAdd to basket -
Clinical research
Kisspeptin-54
£63.005 mgBatch file pendingLonger-lived isoform with direct human oocyte-maturation research, unlike the shorter kisspeptin-10.
UnavailableAsk about availability -
Preclinical
KPV
Price range: £27.47 through £29.9910 mgBatch file pendingA minimal anti-inflammatory alpha-MSH fragment rather than an antimicrobial peptide such as LL-37.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Experimental
Livagen
£46.0020 mgBatch file pendingA liver-tissue bioregulator concept rather than a systemic metabolic receptor agonist.
UnavailableAsk about availability -
Early human evidence
LL-37
£59.005 mgBatch file pendingDirect antimicrobial membrane activity separates it from immune regulators such as KPV or thymosin alpha-1.
UnavailableAsk about availability -
Phase 2 clinical research
MOTS-c
£35.64Batch file pendingMOTS-c begins inside mitochondria and is studied for cell-wide energy adaptation, rather than directly targeting appetite receptors.
Available · 30 in stockAdd to basket -
Clinical research
NAD+
Price range: £52.99 through £72.99500 mg | 1000 mgBatch file pendingNAD+ is a metabolic coenzyme rather than a peptide or receptor agonist, so it belongs to cellular-metabolism research…
AvailableAdd to basket This product has multiple variants. The options may be chosen on the product page -
Established
Oxytocin
£42.0010 mgBatch file pendingA licensed endogenous hormone with direct smooth-muscle effects, not a kisspeptin/GnRH-axis activator.
UnavailableAsk about availability -
Experimental
P21
£58.0010 mgBatch file pendingA CNTF-lineage neurotrophic research material whose exact sequence must be verified before meaningful comparison.
UnavailableAsk about availability -
Early human evidence
Pal-GHK
£38.0010 mgBatch file pendingPalmitoylation—not copper binding—is the defining modification.
UnavailableAsk about availability -
Experimental
PEG-MGF
£61.002 mgBatch file pendingA modified splice-variant fragment rather than a direct full IGF-1 receptor analogue.
UnavailableAsk about availability -
Experimental
Pinealon
£46.0020 mgBatch file pendingA tissue-bioregulator concept with uncertain targets, unlike receptor-defined Semax or Selank research.
UnavailableAsk about availability -
Established
PT-141 (Bremelanotide)
£24.9910 mgBatch file pendingA centrally acting melanocortin agonist, mechanistically separate from reproductive-axis peptides such as kisspeptin.
Available · 20 in stockAdd to basket -
Phase 3 clinical research
Retatrutide
Price range: £49.99 through £209.9910 mg | 20 mg | 30 mg | 40 mg | 50 mg | 60 mgBatch file pendingIt is the only triple-receptor agonist in this catalogue: GIP, GLP-1 and glucagon.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Experimental
Retatrutide + Cagrilintide
£59.995 mg + 5 mg | 10 mg + 10 mgBatch file pendingIt combines triple-receptor agonism with a separate amylin pathway, rather than adding another agent acting through the same…
AvailableAdd to basket This product has multiple variants. The options may be chosen on the product page -
Early human evidence
Selank
Price range: £34.99 through £52.9910 mgBatch file pendingTuftsin-derived and primarily anxiolytic/neuroimmune in focus, unlike the ACTH-derived Semax.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Established
Semaglutide
£69.005 mgBatch file pendingA single-pathway GLP-1 comparator rather than a dual or triple incretin agonist.
UnavailableAsk about availability -
Early human evidence
Semax
Price range: £24.99 through £42.9910 mgBatch file pendingACTH-fragment lineage and neuroprotection focus distinguish it from Selank’s tuftsin/anxiety profile.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Established
Sermorelin
£49.005 mgBatch file pendingClosest to the natural active GHRH sequence and shorter acting than tesamorelin or CJC-1295 DAC.
UnavailableAsk about availability -
Early human evidence
SNAP-8
£35.0010 mgBatch file pendingA topical neurotransmitter-release-mimetic cosmetic peptide rather than a matrix-remodelling peptide.
UnavailableAsk about availability